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Inﬂammatory cytokines and microbe-borne immunostimulators have emerged as triggers of depressive
behavior. Behavioral alterations affect patients chronically infected by the parasite Trypanosoma cruzi. We
have previously shown that C3H/He mice present acute phase-restricted meningoencephalitis with per-
sistent central nervous system (CNS) parasitism, whereas C57BL/6 mice are resistant to T. cruzi-induced
CNS inﬂammation. In the present study, we investigated whether depression is a long-term consequence
of acute CNS inﬂammation and a contribution of the parasite strain that infects the host. C3H/He and
C57BL/6 mice were infected with the Colombian (type I) and Y (type II) T. cruzi strains. Forced-swim
and tail-suspension tests were used to assess depressive-like behavior. Independent of the mouse lineage,
the Colombian-infected mice showed signiﬁcant increases in immobility times during the acute and
chronic phases of infection. Therefore, T. cruzi-induced depression is independent of active or prior
CNS inﬂammation. Furthermore, chronic depressive-like behavior was triggered only by the type I
Colombian T. cruzi strain. Acute and chronic T. cruzi infection increased indoleamine 2,3-dioxygenase
(IDO) expression in the CNS. Treatment with the selective serotonin reuptake inhibitor (SSRI) ﬂuoxetine
abrogated the T. cruzi-induced depressive-like behavior. Moreover, treatment with the parasiticide drug
benznidazole abrogated depression. Chronic T. cruzi infection of C57BL/6 mice increased tumor necrosis
factor (TNF) expression systemically but not in the CNS. Importantly, TNF modulators (anti-TNF and pen-
toxifylline) reduced immobility. Therefore, direct or indirect parasite-induced immune dysregulation
may contribute to chronic depressive disorder in T. cruzi infection, which opens a new therapeutic path-
way to be explored.
 2012 Elsevier Inc. Open access under the Elsevier OA license.1. Introduction production of the pro-inﬂammatory cytokines interferon-gammaStressors such as inﬂammatory cytokines have emerged as trig-
gers of depressive behavior (Dantzer et al., 2008; Maes et al., 2009).
Microbe-borne molecules such as lipopolysaccharide (LPS) (Gibb
et al., 2011) and the human immunodeﬁciency virus type 1 (HIV-
1) Tat protein (Fu et al., 2011) induce cytokine-associated depres-
sive-like behavior in mice. Furthermore, sustained increases in theiologia das Interações, Insti-
neiro 21045-900, Brazil. Tel.:
ce da Silva), lannes@ioc.ﬁo-
sevier OA license.(IFNc) and tumor necrosis factor (TNF) and an enhanced activation
of the tryptophan-catabolizing enzyme indoleamine 2,3-dioxygen-
ase (IDO) induced by Bacillus Calmette-Guerin (BCG) have been
shown to be associated with depressive-like behavior (Moreau
et al., 2008). More recently, studies assessing the acute central
administration of TNF have reinforced the importance of pro-
inﬂammatory cytokines in the pathophysiology of depression (Kas-
ter et al., 2012). In Chagas disease, a neglected tropical disease
caused by the protozoan parasite Trypanosoma cruzi (Lannes-Vieira
et al., 2010), evidence of central nervous system (CNS) abnormali-
ties in chronic patients includes alterations in quantitative electro-
encephalograms, sleep dysfunction, memory impairment and
depression (Prost et al., 2000; Silva et al., 2010), although the
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of infection, T. cruzi colonizes the CNS of humans and experimental
models (Pittella, 2009; Silva et al., 2010). The transition from acute
to chronic infection is accompanied by a decline in systemic para-
site load and CNS parasitism in response to an effective immune
response (Roffê et al., 2003; Junqueira et al., 2010; Silva et al.,
2010). In contrast to the cardiomyopathy associated with myocar-
ditis (Freitas et al., 2005), inﬂammation in the CNS is rare in the
chronic phase, even though the parasite persists in the nervous tis-
sue in an apparently silent manner (Silva et al., 2010). The exis-
tence of a chronic nervous form of Chagas disease remains a
matter of debate (Silva et al., 2010). Although neurologic involve-
ment has been considered to be independent of heart lesions (Prost
et al., 2000), neurocognitive dysfunctions and mood disorders such
as depression have been proposed as secondary consequences of
inﬂammatory heart disease (Mosovich et al., 2008). The severity
of Chagas’ heart disease is associated with an immune dysbalance
that favors IFNc and TNF over interleukin (IL)-10 in the cardiac tis-
sue and periphery (Dutra et al., 2009). However, the participation
of cytokines in mood disorders associated with Chagas disease
has not been explored.
In an attempt to understand the complexity of the involvement
of the CNS in T. cruzi infection, we have previously shown that
C3H/He (H-2k) mice infected with the Colombian strain develop se-
vere meningoencephalitis with enrichment in macrophages and
CD8+ T-cells that is restricted to the acute infection, whereas
C57BL/6 (H-2b) mice are resistant to T. cruzi-induced meningoen-
cephalitis (Silva et al., 1999; Roffê et al., 2003). In both mouse lin-
eages, acute myocarditis progresses to chronic cardiomyopathy
that occurs in a pro-inﬂammatory milieu (Medeiros et al., 2009;
Silverio et al., 2012).
The present work was conducted to test the hypothesis that, in
Chagas disease, chronic mood disorders are long-term conse-
quences of acute T. cruzi-induced CNS inﬂammation. Toward this
end, we used murine models and focused on tests that explore psy-
chomotor skills and depressive-like behavior. Once a depressive
phenotype was observed in T. cruzi-infected mice, we determined
the abilities of the antidepressant ﬂuoxetine and the parasiticide
drug benznidazole to ameliorate depression in this model. Further-
more, because the genetic diversity of T. cruzi strains may contrib-
ute to the pathogenesis of Chagas disease (Zingales et al., 2012), we
tested whether the infecting T. cruzi strain affects behavioral
changes. Lastly, because an immunological dysbalance with high
TNF plasma levels is a feature of chronic Chagas disease (Dutra
et al., 2009; Lannes-Vieira et al., 2011), we also investigated the
existence of an inﬂammatory component in T. cruzi-induced
depressive-like behavior by targeting TNF.2. Methods
2.1. Animals
Four- to six-week-old female mice of the C3H/He (H-2k) or
C57BL/6 (H-2b) lineages with an average weight of between 15–
22 g were obtained from the animal facilities of the Oswaldo Cruz
Foundation (CECAL, Rio de Janeiro, Brazil). The infected and unin-
fected experimental groups of animals consisted of 3–10 mice
per group. All experimental procedures were repeated twice or 3
times. The experimental groups consisted of the following: 6 ani-
mals of each lineage per experiment to follow parasitemia
(Fig. 1A); 10 animals of each lineage per experiment to follow sur-
vival (Fig. 1B); 5 animals of each lineage per experimental point to
follow CNS inﬂammation and parasitism (Fig. 1A and B, Table S1);
10 non-infected (NI), 8 acutely and 6 chronically T. cruzi-infected
C57BL/6 mice for examination in the open-ﬁeld test (Fig. S1); 8NI and 9 T. cruzi-infected mice of each lineage per experimental
point for examination in the open-ﬁeld test (Fig. 2); 10 NI, 7
acutely and 7 chronically T. cruzi-infected C3H/He mice for exam-
ination in the open-ﬁeld test (Fig. S2); 3 NI and 5 T. cruzi-infected
C57BL/6 mice and 4 NI and 6 T. cruzi-infected C3H/He mice per
experiment to evaluate body weight in a kinetic study (Fig. S3A
and S3B); 7 NI and 8 T. cruzi-infected C57BL/6 or C3H/He mice
per experimental point to evaluate body weight and temperature
(Fig. S3C-S3H); 8 NI and 9 T. cruzi-infected C3H/He mice per exper-
imental point and 5 NI and 10 T. cruzi-infected C57BL/6 mice per
experimental point subjected to the tail-suspension test (TST)
and, sequentially, to the forced-swim test (FST) (Fig. 3); 6 T. cru-
zi-infected C3H/He mice to follow parasitemia (Fig. 4A); 3 NI and
5 T. cruzi-infected C3H/He mice per experimental point to perform
TST and immunohistochemical studies (Fig. 4B–D); 9 NI and 30 T.
cruzi-infected C3H/He mice for the kinetic study (Fig. 5A); 4–5 NI
and 7–10 T. cruzi-infected C3H/He or C57BL/6 mice per experimen-
tal group to be checked for body weight and rectal temperature,
submitted to the indicated treatment and subjected to the TST
and, sequentially, to the FST and studies for detection of mRNA
(Fig. 5B–F); 10 NI and 5–16 acutely T. cruzi-infected C3H/He mice
per experimental group submitted to the indicated treatment
and subjected to the TST (Fig. 6A and B, Table 1) and studies for
detection of mRNA (Fig. 7C); 5 NI and 3–10 chronically T. cruzi-in-
fected C3H/He mice per experimental group submitted to the indi-
cated treatment and subjected to the TST (Fig. 6C); 3–4 NI and 4–
10 T. cruzi-infected C57BL/6 mice per experimental group submit-
ted to the indicated treatment and subjected to the TST and studies
for detection of mRNA (Fig. 7). The animals were housed in poly-
propylene cages that measured 30  20  13 cm and covered by
a stainless steel lid. The mice were housed in groups of 5. The bed-
ding material consisted of sterile wood chips. The animals were
maintained under standard conditions (with temperature and rel-
ative humidity of approximately 22 ± 2 C and 55 ± 10%, respec-
tively) and received food and water ad libitum. This study was
conducted in strict accordance with the recommendations in the
Guide for the Care and Use of Laboratory Animals of the Brazilian
National Council of Animal Experimentation (http://www.co-
bea.org.br/) and Federal Law 11.794 (October 8, 2008). The Institu-
tional Committee for Animal Ethics of Fiocruz approved all
procedures (CEUA/Fiocruz, License 004/09).
2.2. Parasites and experimental T. cruzi infection
Mice were infected intraperitoneally with 100 blood trypomas-
tigote (bt) forms of the type I Colombian strain of T. cruzi (Zingales
et al., 2012), which is considered myotropic (Melo and Brener,
1978) and has previously been shown to colonize the CNS (Silva
et al., 1999; Roffê et al., 2003). The parasite was maintained by se-
rial passage in mice every 35 days post-infection (dpi). Parasitemia
was quantitated weekly during the acute and chronic infection
phases using Brener’s method from 5 lL of tail vein blood; the
presence of the rare trypomastigotes marked the onset of the
chronic phase as previously described (Silva et al., 1999; dos Santos
et al., 2001). In some experiments, the animals were infected with
500-bt of the type II Y strain (Zingales et al., 2012), which is consid-
ered macrophagotropic (Melo and Brener, 1978). This strain was
maintained by serial passage in mice every 8 dpi.
2.3. Behavioral tests
All behavioral experiments occurred during the light phase be-
tween 8:00 am and 6:00 pm and were recorded with a DSC-
DVD810 video camera (Sony, USA). To minimize stress and maxi-
mize familiarity, all behavioral tests applied to the different exper-
imental groups were conducted in an environment with a 12-h
Fig. 1. C3H/He mice are susceptible to acute Trypanosoma cruzi-induced CNS inﬂammation and C57BL/6 mice are resistant. C3H/He and C57BL/6 mice were infected with
100-bt forms of the type I Colombian T. cruzi strain. (A) Mice of the C3H/He lineage presented more parasitemia during the acute phase (7–49 dpi) compared with C57BL/6
mice. In the chronic phase (90–120 dpi), few to no parasites were detected in the peripheral blood of mice of either lineage. The means ± SD of parasites/mL of peripheral
blood are shown. (B) A survival curve revealing that approximately 80% of the T. cruzi-infected C3H/He and C57BL/6 mice survived the acute phase and developed chronic
infection. (C) Photomicrographs of the hippocampus of T. cruzi-infected C3H/He mice at the acute phase (30 dpi) showing the presence of T. cruzi amastigote forms inside glial
cells. The upper-left panel shows amastigote forms (green color) revealed by staining with the anti-parasite antibody followed by FITC-conjugated secondary antibody. The
lower-left panel shows a glial cell stained with anti-GFAP (astrocyte; red color) revealed with TRITC-conjugated secondary antibody. The upper-right panel shows the co-
localization (yellow) of T. cruzi amastigote forms (red), revealed by the anti-parasite antibody followed by TRITC-conjugated secondary antibody, inside F4/80+ cells
(microglial cells, green) stained with anti-F4/80 antibody followed by FITC-conjugated secondary antibody. The lower-right panel shows the co-localization (yellow) of T. cruzi
amastigote forms (green), revealed by the anti-parasite antibody followed by FITC-conjugated secondary antibody, inside GFAP+ cells (astrocytes, red) stained with anti-GFAP
followed by TRITC-conjugated secondary antibody. Left panels, Bar = 50 lm. Right panels, Bar = 200 lm. (D) Photomicrographs of the hippocampus of T. cruzi-infected C3H/
He and C57BL/6 mice at the acute (30 dpi) and chronic (90 dpi) phases of infection. The upper-left panel shows the presence of inﬂammatory mononuclear cells dispersed
throughout the parenchyma in acutely infected C3H/He mice. The inserted photomicrograph in the upper-left panel shows the adhesion of mononuclear cells to the
endothelial cells of a blood vessel of the cerebellum. The upper-right panel shows a photomicrograph of the hippocampus of T. cruzi-infected C57BL/6 mice and reveals the
absence of inﬂammatory cells. The lower panels show photomicrographs of hippocampus of T. cruzi-infected C3H/He (left) and C57BL/6 (right) mice with absence of
inﬂammation in the chronic phase (90 dpi) of infection. The inserted photomicrograph in the lower-left panel shows the hippocampus of NI C3H/He mice. Bar = 200 lm,
400 lm in upper-left insert and 600 lm in lower-left insert.
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Fig. 2. The absence of locomotor and exploratory abnormalities in Trypanosoma cruzi-infected C3H/He mice. Mice were infected with 100-bt forms of the type I Colombian T.
cruzi strain. NI sex- and age-matched controls and T. cruzi-infected mice were subjected to the open-ﬁeld test for ﬁve-minute sessions. The graphs show the number of
peripheral and central lines crossed and the numbers of rearings in the (A) acute (30 dpi) and (B) chronic (90 dpi) phases of infection. Each symbol indicates one mouse. Data
are expressed as the mean ± SD. The groups consisted of 8 to 9 infected mice per test. This ﬁgure is representative of three independent experiments.
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ambient noise level of approximately 40 dB produced by an air
conditioner. To analyze depressive and locomotor/exploratory
activity, the animals were subjected to the behavioral tests starting
at 7 dpi or from 30 to 42 dpi (acute phase) and at 90 or 120 dpi
(chronic phase) when the animals were infected with the Colom-
bian strain and at 7, 14 and 21 dpi (acute phase) and 28 and
35 dpi (chronic phase) for the Y strain. In experiments with inter-
vention during the chronic infection with the Colombian strain,
treatment started at 120 dpi and the animals were subjected to
behavioral tests at 150 dpi. When animals were re-used, the tests
were performed on consecutive days according to the following se-
quence: day 1, open-ﬁeld test; day 2, TST; day 3, FST. No animal
was re-tested. To further assess sickness alterations that might
have contributed to behavioral alterations (Rogers et al., 2001),
we checked rectal temperature with a rectal probe (Thermometer
DT-610B, ATP, USA), apathy and body weight loss.
2.3.1. The open-ﬁeld test
Emotionality, locomotor and exploratory activity were tested
using a modiﬁed version of the open-ﬁeld arena; because the ani-
mals have never been in the test environment, they tend to explore
it (Hall, 1941). The open ﬁeld was a white wooden arena measur-
ing 60  60 cm (3600 cm2). The ﬂoor of the apparatus was divided
by black grid lines into 49 squares of approximately 8.5 cm each
and two imaginary areas – the periphery (40 squares along the
walls) and center (9 squares in the central area of the apparatus).
Each mouse was placed at the same location in a corner square
of the peripheral area. After initial tests using different times of
observation (ﬁve-, ten- and thirty-minute test sessions), the assay
was established and the animals were tested in ﬁve-minute ses-
sions. Activities were recorded using a video camera (Sony, USA).
To assess the number of behavioral elements, the following param-
eters were utilized: (i) outer locomotor activity, i.e., when the ani-mals crossed each grid line with all four paws in the peripheral
area; (ii) inner locomotor activity, i.e., when the animals crossed
each grid line with all four paws in the central area; and (iii) rear-
ing activity, i.e., when the animals rose on their hind legs. The
apparatus was cleaned with 70% alcohol and dried with gauze be-
tween tests.
2.3.2. The tail-suspension test (TST)
Animals subjected to the short-term, inescapable stress of being
suspended by their tail will develop an immobile posture. Immo-
bility is deﬁned as the absence of initiated movements and in-
cludes passive swaying. In this test, adapted from Steru and co-
workers (1985), the mouse was hung upside-down using adhesive
tape to ﬁx its tail to a vertical surface (an iron rod with a height of
30 cm). A square platform made of white wood was positioned
horizontally 20 cm below the iron rod, just under the mouse’s fore-
paws, in such a way that the mouse could lightly touch the plat-
form and minimize the weight sustained by its tail until the
recording began. The animal’s behavior was recorded with a video
camera for 5 min (Sony, USA). The total time of immobility was
measured. The animal was considered immobile when it was not
struggling, attempting to catch the adhesive tape or showing body
torsion or jerky movements.
2.3.3. The forced-swim test (FST)
The FST procedure consisted of placing the mouse inside a
cylindrical glass tank (height 35 cm, diameter 25 cm) containing
clean water at 24–26 C to a level of 20 cm above the bottom
(adapted from Porsolt, 2000). The animals were left in the cylinder
for 6 min. After the ﬁrst 2 min, the total duration of immobility was
measured over a period of 4minutes. The mouse was considered to
be immobile when it remained ﬂoating passively in the water or
was making slight movements to keep its head above the water.
A video camera (Sony, USA) was placed on top of the water tank
Fig. 3. Infection by the type I Colombian Trypanosoma cruzi strain induces
depressive-like behavior in murine models. C3H/He and C57BL/6 mice were
infected with 100-bt forms of the Colombian strain. The graphs indicate the time
of immobility in the (A) FST and (B) TST in the acute (30 dpi; left panels) and chronic
(90 dpi; right panels) phases of infection of C3H/He mice compared with sex- and
age-matched NI controls. (C) The graphs show the time of immobility observed in
the TST for C57BL/6 mice during the acute (30 dpi; left panel) and chronic (90 dpi;
right panel) phases of infection. The quantiﬁcation was over a period of four-minute
sessions for the FST and ﬁve-minute sessions for the TST, using different groups of
animals in each test. The time of immobility is expressed in seconds. Each symbol
indicates one mouse. Data are expressed as the mean ± SD. The groups consisted of
5 to 10 mice per each test. This ﬁgure is representative of two independent
experiments. ⁄p < 0.05; ⁄⁄⁄p < 0.001.
Fig. 4. Infection by the type II Y Trypanosoma cruzi strain did not induce chronic
depressive-like behavior. C3H/He mice were infected with 500-bt forms of the Y
strain. (A) The peak of parasitemia occurred at 7–8 dpi. At 18 dpi, no parasites were
detected in the peripheral blood and this marked the onset of chronic infection in
this model. (B) The graph shows that when mice were subjected to the TST,
increased immobility time was observed from 7 and 14 dpi. At 28 and 35 dpi, the
immobility times in infected mice were similar to those of NI sex- and age-matched
controls. The quantiﬁcation was over a period of ﬁve-minute sessions for the TST.
Data are expressed as the mean ± SD. (C) Representative photomicrographs of the
encephalons of T. cruzi-infected C3H/He mice showing the absence of parasite
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of each animal. After the test, the animal was dried with gauze and
returned to its cage.antigens at 7 dpi and the presence of parasite-positive areas in the encephalons of T.
cruzi-infected mice at 14, 28 and 35 dpi. (D) The quantiﬁcation of T. cruzi-positive
stained areas in the encephalons of T. cruzi-infected C3H/He mice from 7 to 35 dpi.
These results represent three sections of the brains of three mice per experimental
group. Data are expressed as the mean ± SD. The groups consisted of 5 to 6 infected
mice per time point. This ﬁgure is representative of two independent experiments.
Bar = 300 lm (upper panel), 600 lm (lower panel). ⁄p < 0.05; ⁄⁄⁄p < 0.001.2.4. Fluoxetine treatment
Groups of 7–10 infected and 3–5 sex- and age-matched NI con-
trol animals were treated with the selective serotonin reuptake
Fig. 5. Trypanosoma cruzi-induced depressive-like behavior is paralleled by increased expression of IDO mRNA in the CNS and is reversed by the SSRI antidepressant
ﬂuoxetine. C3H/He mice were infected with 100-bt forms of the Colombian strain. (A) Signiﬁcantly increased immobility in the FST was detected at 21 dpi and afterward. (B)
An elevated expression of IDOmRNA transcripts in whole brain extracts was observed in acutely and chronically infected mice in comparison with NI controls. IDO expression
was estimated by RT-qPCR. The upper photomicrograph of a representative gel shows the expected PCR products (100 bp): Molecular weight marker, MW (Lane 1); negative
template control, – (Lane 2); the detection of IDO mRNA in the NI control (Lane 3), acutely (Lane 4) and chronically (Lane 5) T. cruzi-infected mice; the detection of b actin
mRNA in the NI control (Lane 6), acutely (Lane 7) and chronically (Lane 8) T. cruzi-infected mice; the detection of GAPDH mRNA in the NI control (Lane 9), acutely (Lane 10)
and chronically (Lane 11) T. cruzi-infected mice. The graph shows the increased IDO mRNA expression in acutely and chronically T. cruzi-infected mice. The data were
normalized using the housekeeping genes b actin and GAPDH. The data are shown as fold increases of IDO mRNA in infected mice in comparison with NI controls. The ﬁgure is
representative of three experiments with two NI and three infected mice per group. (C) The experimental design showing that C3H/He and C57BL/6 mice were infected with
100-bt forms of the Colombian strain. At 14 dpi, the mice were treated with ﬂuoxetine (FX) by gavage with 0.1 mL volume at 10 mg/kg for 20 consecutive days (from 14 to
34 dpi) and subjected to the behavioral tests at 35 dpi. Weight loss was observed in FX-treated mice in comparison with saline-treated mice during the all periods of
treatment. (D) The graph indicates the time of immobility in the FST for NI and T. cruzi-infected C3H/He mice not treated (Nt), vehicle-treated (Saline) or FX-treated (FX). (E)
The graph indicates the time of immobility in the TST for NI and T. cruzi-infected C3H/He mice not treated (Nt), vehicle-treated (Saline) or FX-treated (FX). (F) The graph
indicates the time of immobility in the TST for NI and T. cruzi-infected C57BL/6 mice not treated (Nt), vehicle-treated (Saline) or FX-treated (FX). Data are expressed as the
mean ± SD. Each group consisted of 4 to 9 infected mice. The ﬁgure represents two independent experiments. ⁄p < 0.05; ⁄⁄p < 0.01; ⁄⁄⁄p < 0.001.
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mals were treated daily by gavage with 0.1 mL of 10 mg/kg of FX
(Prozac, Eli Lilly, Brazil) or injection-grade saline (BioManguinhos,
Fiocruz, Brazil) from 14 to 34 dpi. Twenty-four hours after the last
dose of FX, the animals were subjected to the TST or FST. Parasite-
mia and survival rates were evaluated daily. Animals were sacri-
ﬁced under anesthesia at 35 dpi and the hearts and encephalons
were collected.2.5. Benznidazole treatment
Groups of 5–10 Colombian-infected and 5 sex- and age-
matched NI control animals were treated daily with 100 mg/kg/
day of the trypanocide drug benznidazole (Bz, LAFEPE, Brazil) dur-
ing acute T. cruzi infection (from 14 to 34 dpi, by gavage). The lev-
els of parasitemia were evaluated as previously described. Twenty-
four hours after the last dose of Bz, the mice were subjected to the
Fig. 6. Trypanosoma cruzi-induced depressive-like behavior is abrogated by the
trypanocide drug benznidazole. No reciprocal interference was observed when
ﬂuoxetine and benznidazole were combined. (A) The experimental design shows
that C3H/He mice were infected with 100-bt forms of the Colombian strain, treated
with saline, ﬂuoxetine (FX) by gavage with 0.1 mL volume at 10 mg/kg, benzni-
dazole (Bz) by gavage with 100 mg/kg/day or the combination of FX and Bz
(FX + Bz) for 20 consecutive days (from 14 to 34 dpi), subjected to the TST at 35 dpi
and compared with non-infected controls (NI). The graph indicates the time of
immobility in seconds. The data support the idea that FX, Bz and FX + Bz have
beneﬁcial effects in abrogating T. cruzi-induced depressive-like behavior. (B)
Photomicrographs showing the presence or absence of T. cruzi-positive areas in
the encephalon parenchyma of T. cruzi-infected C3H/He mice during the acute
phase of infection (35 dpi) after treatment with saline (upper-left panel), FX (upper-
right panel), Bz (lower-left panel) or FX + Bz (lower-right panel). The inserted
photomicrograph in the upper-right panel shows the encephalon parenchyma of NI
C3H/He mice. The data show that Bz treatment was efﬁcacious in controlling CNS
parasitism, FX treatment did not have an effect and FX did not alter Bz efﬁcacy.
Bar = 200 and 400 lm in inserts. (C) The experimental design shows that NI and T.
cruzi-infected C3H/He mice were treated with vehicle (Saline) or Bz (Bz) from 14 to
44 dpi and subjected to the TST at 90 dpi. The graph indicates the time of
immobility in seconds. The ﬁndings support a long-lasting beneﬁcial effect of Bz in
abrogating T. cruzi-induced depressive-like behavior. Data are expressed as the
mean ± SD. Each group consisted of 3 to 10 mice. The ﬁgure represents two
independent experiments. ⁄p < 0.05; ⁄⁄p < 0.01; ⁄⁄⁄p < 0.001.
Table 1
Parasitemia observed before and after the treatment with the SSRI antidepresant drug
ﬂuoxetine and/or the trypanocide drug benznidazole in the experimental T. cruzi
infection.
Experimental group Parasitemia (x104 parasites/mL)
14 dpi Before treatment 35 dpi After treatment
T. cruzi + saline 0.52 ± 0.83 328.30 ± 109.90
T. cruzi + FX 0.62 ± 0.58 272.81 ± 116.80
T. cruzi + Bz 0.24 ± 0.34 0*
T. cruzi + FX + Bz 0.62 ± 0.51 0*
* p < 0.05; when compared with T. cruzi + saline
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lons were collected. In other experiments, the animals were trea-
ted with Bz for 30 days (from 14 to 44 dpi, by gavage) and
subjected to the TST at 90 dpi (chronic phase).
2.6. Anti-TNF treatment
Chronically T. cruzi-infected (120 dpi) C57BL/6 mice were sub-
cutaneously treated with injection-grade saline (BioManguinhos-
Fiocruz, Brazil) containing 10 lg of the mouse/human chimeric
anti-mouse TNF blocking monoclonal antibody inﬂiximab (Remi-
cade), a gift from Schering-Plough of Brazil, at 48-h intervals over
30 days. Inﬂiximab has been previously shown to block in vivo
TNF biological activity in murine models (Redlich et al., 2002; Tra-
cey et al., 2008).
2.7. Pentoxifylline treatment
Chronically T. cruzi-infected (120 dpi) C57BL/6 mice were intra-
peritoneally treated daily with injection-grade saline (BioMangu-
inhos-Fiocruz, Brazil) containing 20 mg/kg pentoxifylline (PTX,
Trental, Sanoﬁ, Brazil) for 30 days. PTX is a phosphodiesterase
inhibitor that has previously been shown to suppress TNF gene
transcription (Doherty et al., 1991) and thereby prevent TNF syn-
thesis and attenuate TNF increases in response to in vivo endotox-
ins (Zabel et al., 1989).
2.8. Histopathological studies and immunohistochemical staining
(IHS)
According to the experimental protocol, groups of 5–7 infected
mice and 3 to 5 NI sex- and age-matched control mice were sacri-
ﬁced under anesthesia at various time points after infection. The
encephalons were removed, embedded in tissue-freezing medium
(Tissue-Tek, Miles Laboratories, USA) and stored in liquid nitrogen
for analysis by IHS. Serial cryostat sections (3-lm thick) were ﬁxed
in cold acetone and stained with hematoxylin and eosin (H&E) or
subjected to indirect immunoperoxidase or immunoﬂuorescence
staining. The H&E-stained sections were examined using light
microscopy and scored as previously described (Silva et al.,
1999). For indirect immunoperoxidase staining, parasite antigens
were revealed by staining with the polyclonal anti-T. cruzi antibody
(produced in our laboratory, LBI/IOC-Fiocruz, Brazil), as previously
described (Silva et al., 1999). For confocal microscopy, parasite
antigens were revealed with the same anti-T. cruzi antibody except
that the secondary antibody goat anti-rabbit immunoglobulin was
labeled with FITC or TRITC (Amersham, England). Astrocytes and
microglial cells were revealed with puriﬁed anti-glial ﬁbrillary
acidic protein (GFAP) antibody (Amersham, England) and puriﬁed
anti-F4/80 rat antibody (Caltag, USA), respectively. Secondary
anti-rat immunoglobulins labeled with FITC or TRITC (Amersham,
England) were used to reveal glial cells. For positive controls, heart
tissue sections from T. cruzi-infected mice at 30 dpi were used. For
Fig. 7. Trypanosoma cruzi-induced chronic depressive-like behavior is reversed by
TNF-targeting pentoxifylline and anti-TNF antibodies. C57BL/6 mice were infected
with 100-bt forms of the Colombian strain and compared with NI sex- and age-
matched controls. (A) The graph shows the TNF concentration in the serum of non-
infected (NI) or chronically (120 dpi) infected mice as assessed by ELISA. (B) In
comparison with NI controls, no signiﬁcant difference in the TNF mRNA expression
was detected by semi-quantitative PCR in the whole brain extracts, but increased
TNF mRNA was observed in the heart tissue extracts of chronically (120 dpi)
infected C57BL/6 mice. Data are expressed as the mean ± SD. Each group consisted
of 6 to 8 mice. (C) The experimental design showing that mice were treated with
ﬂuoxetine (FX) by gavage with 0.1 mL volume at 10 mg/kg for 20 consecutive days
(from 14 to 34 dpi), the hearts were collected and subjected to RT-qPCR for the
evaluation of TNF mRNA. Similar TNF mRNA expression was detected by RT-qPCR in
the cardiac tissue of saline- and FX-treated infected mice at the end point of the
treatment. The results are representative of three independent experiments with
two NI controls and three T. cruzi-infected mice per group. (D) The experimental
design shows that the infected mice were treated with vehicle (saline), pentoxif-
ylline (PTX; daily) or anti-TNF antibody (inﬂiximab; at 48-h intervals) for 30 days
and subjected to the TST at 150 dpi. The graph shows the beneﬁcial effect of PTX
and anti-TNF treatment on the time of immobility compared with saline admin-
istration in T. cruzi-infected mice. Each symbol represents one mouse. Data are
expressed as the mean ± SD. Each group consisted of 3 to 6 mice. The ﬁgure
represents two independent experiments. ⁄p < 0.05; ⁄⁄p < 0.01.
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subjected to all the steps of the reaction excluding the addition
of the primary antibodies. The images were analyzed with a confo-
cal microscope (LSM 410, Zeiss, Germany). The presence of T. cruzi
antigens in brain tissue sections was also evaluated with a digital
morphometric apparatus. The images were analyzed with the
AnaliSYS Program and the areas containing parasite molecules
were identiﬁed as amastigote nests in microscopic ﬁelds. Three
whole sections were analyzed per brain.
2.9. The immunoenzymatic assay for TNF
TNF was assayed with the ELISA sandwich development kit as-
say from R&D (catalog # 900-k57 lot # 0104054) with rat anti-TNF
mAb and a biotin-labeled polyclonal rabbit serum speciﬁc for the
cytokine. TNF levels were calculated by reference to a standard
curve constructed with recombinant cytokine. The sensitivity of
this method was 10 pg/mL. The assay was developed using the
2,20-azino-bis (3-ethylbenzthiazoline-6-sulfonic acid) substrate
(Sigma, USA) and the reaction was stopped with 20 lL of 20% sul-
furic acid solution. The optical density (OD) was read with a micro-
plate reader set to 405 nm.
2.10. RT-PCR assay for TNF mRNA
For reverse transcriptase PCR (RT-PCR), mRNA was isolated
from the whole encephalon and heart tissue of the C57BL/6 mice
by acid guanidinium thiocyanate–phenol–chloroform extraction.
The RNA STAT-60 reverse transcriptase-PCR conditions, primer se-
quences used for the detection of TNF, housekeeping gene hypo-
xanthine–guanine phosphoribosyltransferase (HPRT) and PCR
product sizes have been published elsewhere (dos Santos et al.,
2001). The PCR products and a molecular weight marker were elec-
trophoresed in 6% polyacrylamide gel and stained with silver ni-
trate. The densitometry analysis of the gels was conducted on a
Densitometer CS-9301PC (Shimadzu, Japan). The PCR data were
standardized using mRNA of the housekeeping gene HPRT and fold
increases were determined by a comparison with NI controls.
2.11. Real-time quantitative RT-PCR for TNF and IDO mRNA
For real-time quantitative RT-PCR (RT-qPCR), total RNA from
heart and whole brain samples was extracted using TRI Reagent
(Sigma–Aldrich, USA). All reverse transcriptase reactions were per-
formed on 5-lg RNA using a Superscript III kit (cat# 18080-051,
Invitrogen, USA) according to the manufacturer’s instructions. All
RNA samples were reverse transcribed simultaneously to minimize
the interassay variation associated with the reverse transcription
reaction. Real-time RT-PCR was performed on an ABI Prism 7500
Fast (Applied Biosystems) using Taqman gene expression assays
for the cytokine TNF (cat# Mm00443258-m1) and the trypto-
phan-degrading enzyme indoleamine 2,3-dioxygenase (IDO)
(cat# Mm00492586-m1) purchased from Applied Biosystems
(USA). Reactions were performed in duplicate according to the
manufacturer’s instructions using a 2-lL cDNA template for each
reaction in a total volume of 20 lL. The relative quantitative mea-
surement of target gene levels was performed using the DDCt
method (Livak and Schmittgen, 2001). As endogenous housekeep-
ing control genes, we used the glyceraldehyde 3-phosphate dehy-
drogenase (GAPDH) (cat# Mm99999915-g1) and the b actin (cat#
Mm00607939-s1) genes. The RT-qPCR products and a molecular
weight marker were electrophoresed in 1% agarose gel and stained
with Nancy-520 (Sigma, Switzerland). The RT-qPCR data were
standardized using the mRNA of the housekeeping genes GAPDH
and b actin and fold increases were determined in comparison with
NI controls.
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The data are expressed as the arithmetic mean ± SD. To compare
the two groups (NI and T. cruzi) in the acute and chronic phases,
Student’s t test was adopted to analyze the statistical signiﬁcance
of the apparent differences (Figs. S1, S2, S3C-S3F, 2, 3 and 7A-
7B). The Shapiro–Wilk and Levene tests were used to analyze the
normality (p < 0.05) and homogeneity of variances (p < 0.05),
respectively. Kruskal–Wallis tests with Dunn’s Multiple Compari-
son tests were used to determine whether one parameter varied
among three or more different groups (Figs. 4B, 5A, 5B, 5C, 5E,
6A, 6C and 7D). A one-way ANOVA with the Bonferroni test was
used to compare the treated and non-treated NI and T. cruzi groups
(Fig. 5D and F). Differences were considered statistically signiﬁcant
at p < 0.05. All statistical tests were performed using GraphPad
Prism 5.0 (GraphPad software, USA).3. Results
3.1. The inﬁltration of the CNS by inﬂammatory cells during T. cruzi
infection depends on the genetic background of the host
When acutely infected with the type I Colombian T. cruzi strain,
the C3H/He, but not the C57BL/6, mice showed elevated parasite-
mia. In mice of both lineages, the peak of parasitemia was observed
between 42 and 45 dpi and decreased thereafter; during the
chronic phase of infection, parasites were rarely found in circulat-
ing blood (Fig. 1A). Approximately 80% of the animals survived and
developed chronic infection (Fig. 1B). In a previous work, we
showed that C3H/He mice are susceptible to acute phase-restricted
meningoencephalitis, whereas C57BL/6 mice are resistant to T. cru-
zi-induced CNS inﬂammation (Roffê et al., 2003). In mice of both
lineages during the acute phase, CNS parasitism was mainly de-
tected as amastigote forms of the T. cruzi parasite inside GFAP+
cells (astrocytes) and F4/80+ cells (microglial cells) spread through-
out the brain parenchyma (Fig. 1C). Rarely, parasite-positive areas
were seen during the chronic phase (data not shown). Histopathol-
ogical analyses revealed that in T. cruzi-infected C3H/He mice,
brain inﬂammation was restricted to the acute phase of infection,
when inﬂammatory cells were seen in the parenchyma and peri-
vascular cuffs with one or more layers of inﬁltrating cells
(Fig. 1D). In the acutely infected C3H/He mice, several CNS areas
were affected including hippocampus (Fig. 1D), a brain region in-
volved in depression in mouse models (Bahi and Dreyer, in press).
In contrast, no inﬂammatory inﬁltrates were detected in the brain
of acutely and chronically T. cruzi-infected C57BL/6 mice (Fig. 1D),
resembling the CNS of NI controls. These data are summarized in
Table S1. Therefore, these models allowed us to test whether
behavioral alterations were induced during chronic T. cruzi infec-
tion and whether they were a long-term consequence of acute
CNS inﬂammation.3.2. Locomotor/exploratory alterations are absent in the T. cruzi-
induced CNS inﬂammation-susceptible C3H/He mice but present in the
resistant C57BL/6 mice
To test whether behavioral alterations are present in T. cruzi
infection, we initially subjected infected mice to the open-ﬁeld test
and analyzed the numbers of peripheral and central crossed lines
and rearing episodes. Acutely infected C57BL/6mice exhibited a sig-
niﬁcant (p < 0.001; t (11) > 5.124) decrease in locomotor/explor-
atory activity compared with the NI controls in ﬁve-, ten- and
thirty-minute sessions (Fig. S1A). Chronically T. cruzi-infected
C57BL/6 mice also presented a signiﬁcant decrease in locomotor/
exploratory activity expressed as the reductions in the number ofcrossed peripheral (p < 0.0001; t (9) = 11.89) and central (p < 0.01;
t (9) = 4.107) lines and rearing episodes (p < 0.0001; t (9) = 8.888)
inﬁve-minute sessions (Fig. S1B). This ﬁnding conﬁrmsour previous
data (Silva et al., 2010). Conversely, when T. cruzi-infected C3H/He
mice were compared with sex- and age-matched NI controls, there
were no signiﬁcant differences (p > 0.05; t (6) < 1.500) in the num-
bers of crossed peripheral and central lines or rearing episodes dur-
ing the acute (30 dpi; Fig. 2A) or chronic (90 dpi; Fig. 2B) phases of
infection inﬁve-minute sessions of the open-ﬁeld test. Furthermore,
no signiﬁcant (p > 0.05; t (11) < 1.000) behavioral alterations were
detected in acutely (Fig. S2A) or chronically (Fig. S2B) T. cruzi-in-
fected C3H/He mice when their performances in ten- and thirty-
minute sessions of the open-ﬁeld test were analyzed. Considering
that sickness featuresmay contribute to behavioral alterations such
as decreases in spontaneous locomotor/exploratory activity (Rogers
et al., 2001),we further assessed sickness behavior by checkingbody
weight loss (which reveals loss of appetite), apathy and increase in
temperature (indicativeof fever). During the recorded interval (from
7 to 150 dpi), apathy, characterized as prostration, was not detected
in C3H/He and C57BL/6 mice infected with a low-level inoculum of
the Colombian T. cruzi strain. The kinetic study (from 7 to 90 dpi) of
body weight revealed no signiﬁcant (p > 0.05; t (14) < 2.000) body
weight loss in Colombian-infected C3H/He (Fig. S3A) and C57BL/6
(Fig. S3B) mice. These data were conﬁrmed in temporally speciﬁc
experiments during the acute (Fig. S3C; p > 0.05; t (13) = 1.731)
and chronic (Fig. S3E; p > 0.05; t (12) = 1.489) phases of infection
of C3H/He mice and the chronic infection of C57BL/6 mice
(Fig. S3G; p > 0.05; t (13) = 1.685). During acute infection (30 dpi),
C3H/He mice exhibited no alterations in rectal temperature
(Fig. S3D; p > 0.05; t (13) = 1.250), although a signiﬁcant decrease
in temperature was observed during the chronic phase of infection
(Fig. S3F; p < 0.001; t (12) = 4.535) in comparison with sex- and
age-matched controls. No signiﬁcant (p > 0.05; t (13) = 1.462) alter-
ation in rectal temperature was detected in chronically T. cruzi-in-
fected C57BL/6 mice. Altogether, these data demonstrate that C3H/
HeandC57BL/6mice infectedwith a low inoculumof theColombian
strain do not exhibit signs of sickness behavior. Furthermore, T. cru-
zi-infected C3H/He mice do not show locomotor/exploratory activ-
ity alterations during the acute or chronic phases of infection.
3.3. Depressive-like behavior is present during experimental T. cruzi
infection
We used the FST and TST to assess depressive-like behavior, as
recently described in mouse models of chronic stress (Ma et al.,
2011) and immune challenge with LPS (Painsipp et al., 2011). In
our model, acutely (30 dpi) the Colombian-infected C3H/He mice
showed a signiﬁcant increase in immobility time in the FST com-
pared with NI controls (Fig. 3A; p < 0.001; t (16) = 4.092). Similar
results were obtained when another group of infected mice was
analyzed during the chronic infection phase (90 dpi) compared
with sex- and age-matched NI controls (Fig. 3A; p < 0.001; t
(15) = 5.374). Corroborating these data, Colombian-infected C3H/
He mice showed elevated immobility during the acute (p < 0.001;
t (16) = 5.070) and chronic (p < 0.001; t (14) = 7.355) infection
phases compared with NI mice in the TST (Fig. 3B). Therefore, in
the absence of active CNS inﬂammation, chronically T. cruzi-in-
fected C3H/He mice presented depressive-like behavior that may
have been a result of acute CNS inﬂammation.
3.4. Depressive status is independent of acute T. cruzi-induced CNS
inﬂammation
Our initial hypothesis was that behavioral alterations detected
during chronic T. cruzi infection were long-term consequences of
acute CNS inﬂammation. However, this was not found to be
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duced acute CNS inﬂammation (Fig. 1D), we observed a signiﬁ-
cantly increased immobility time in the TST during the acute
(30 dpi; p < 0.05; t (14) = 2.479) and chronic (90 dpi; p < 0.001; t
(13) = 8.945) phases of infection compared with sex- and age-
matched NI controls (Fig. 3C). Our ﬁndings suggest that T. cruzi-in-
duced depressive-like behavior is present in the acute and chronic
infection phases independent of acute CNS inﬂammation. Hence,
depressive status is not a long-term consequence of the T. cruzi-in-
duced acute brain inﬂammation.
3.5. The type I, but not type II, T. cruzi strain induces chronic
depressive-like behavior
Considering the genotypic and biological diversity of T. cruzi
strains (Zingales et al., 2012), we wondered whether the depres-
sive proﬁle induced by infection with the type I Colombian strain
could also be elicited by the distinct type II Y strain. To investigate
this question, C3H/He mice were infected with 500-bt of the Y
strain and followed daily for parasitemia and mortality. Parasite-
mia was detected as early as 4 dpi, peaked at 7–8 dpi and was con-
trolled subsequently. No circulating parasite was detected at or
after 18 dpi, which marked the resolution of acute infection and
the onset of chronic infection (Fig. 4A). All the infected animals sur-
vived (data not shown). Next, we investigated whether the mice
appeared to be depressed with the TST. A signiﬁcant increase in
immobility was detected at 7 dpi (p < 0.05; at the peak of parasite-
mia) and reached a maximum at 14 dpi (p < 0.001). At 28 and
35 dpi, the immobility of infected mice was similar (p > 0.05) to
that of sex- and age-matched NI controls (Fig. 4B). Importantly,
the duration of immobility time did not correlate with CNS parasit-
ism: at 7 dpi in the Y strain, when behavioral alterations were ﬁrst
detected, no parasites were found by IHS in brain sections. A few
parasites were detected in the CNS tissue at 14 dpi. CNS parasitism
peaked at 28 dpi and declined at 35 dpi (Fig. 4C and D). CNS para-
sitism was found mainly in the cerebellum (data not shown) and
hippocampus (Fig. 4D) at 35 dpi when depressive-like behavior
was not detected in the Y-strain-infected C3H/He mice (Fig. 4B).
Thus, there was no association between CNS parasitism and
depressive-like behavior. Furthermore, the type I Colombian T. cru-
zi strain, but not the type II Y strain, induced chronic depressive-
like behavior in mice.
3.6. T. cruzi-induced depressive-like behavior is associated with
increased IDO mRNA expression in the CNS and abrogated by
treatment with a selective serotonin reuptake inhibitor
Depressive-like behavior was detected in the Colombian-in-
fected C3H/He mice at 30 dpi and persisted until 90 dpi (Fig. 3A
and B). Although a consistent, slight increase in immobility time
was detected at 14 dpi, the onset of depressive-like behavior in
the Colombian-infected C3H/He mice occurred at 21 dpi, when a
signiﬁcant increase in immobility was detected, and persisted dur-
ing the chronic phase (Fig. 5A; p < 0.05; H (5) = 29.46). Given the
participation of tryptophan-degrading enzymes such as IDO in
depression (Dantzer et al., 2008), we investigated the status of
IDO mRNA in the CNS of T. cruzi-infected mice. Compared with
NI controls, an increase in IDO mRNA expression was observed in
the CNS of T. cruzi-infected mice during the acute (30 dpi) and
chronic (90 dpi) phases of infection (Fig. 5B). To further investigate
depressive-like behavior during T. cruzi infection, Colombian-in-
fected C3H/He and C57BL/6 mice were subjected to treatment with
the selective serotonin reuptake inhibitor (SSRI) antidepressant
ﬂuoxetine (FX) from 14 to 34 dpi and analyzed at 35 dpi
(Fig. 5C). As expected (D’Souza et al., 2004), FX-treated mice pre-
sented body weight loss (p < 0.001; H (3) = 19.87) when comparedwith saline-treated infected mice (Fig. 5C). Infected mice treated
with FX exhibited signiﬁcantly decreased immobility times in the
FST when compared with not treated (Nt; p < 0.001; t (2) = 12.19)
or saline-treated (Saline; p < 0.01; t (2) = 10.30) T. cruzi-infected
C3H/He mice (Fig. 5D). These results were corroborated by the
TST (Fig. 5E; p < 0.001; H (2) = 15.68), supporting that FX abrogated
T. cruzi-induced depressive-like behavior. Similarly, FX administra-
tion reduced immobility times in the TST for T. cruzi-infected
C57BL/6 mice compared with Nt (p < 0.001; t (2) = 11.16) or sal-
ine-treated (p < 0.001; t (2) = 10.90) T. cruzi-infected mice
(Fig. 5F). Therefore, T. cruzi infection induced depressive-like
behavior that was independent of CNS inﬂammation but paralleled
the increased IDO mRNA expression in the CNS and was responsive
to the administration of the SSRI antidepressant FX.
3.7. Depressive-like behavior is alleviated by benznidazole treatment
Because our hypothesis that the depressive-like behavior pres-
ent in chronically T. cruzi-infected mice is a long-term consequence
of acute CNS inﬂammation was incorrect, we explored the contri-
bution of the parasite to depressive statuses observed during
experimental infection. C3H/He mice were infected with the
Colombian strain and treated with Bz, a parasiticide drug (Cançado,
2002). Mice were treated with Bz alone or with Bz and FX, to search
for a possible reciprocal interference of the drugs, and subjected to
the TST. After 20 days of treatment (from 14 to 34 dpi), no circulat-
ing parasites were observed in the Bz-treated mice and high num-
bers of circulating parasites were observed in the non-treated and
saline- and FX-treated mice (Table 1). Furthermore, when com-
bined with Bz, FX administration did not alter the efﬁcacy of Bz
(Table 1). Importantly, Bz treatment signiﬁcantly (p < 0.05) de-
creased the immobility time of T. cruzi-infected mice in the TST
compared with saline-treated infected mice (Fig. 6A). Furthermore,
the combined treatment with Bz and FX also signiﬁcantly abro-
gated the depressive-like behavior induced by T. cruzi infection
(Fig. 6A) in a manner similar to that of FX alone (p < 0.001; H
(4) = 33.97); this ﬁnding supports the idea that Bz does not inter-
fere with the actions of FX. Analysis of the CNS by IHS revealed
an absence of parasite antigens in the Bz-treated and Bz + FX-trea-
ted mice (Fig. 6B); this ﬁnding further reinforces the idea that FX
does not interfere with the efﬁcacy of Bz. Conversely, the numbers
of parasite-antigen-positive areas detected in the CNS were similar
in saline- and FX-treated infected mice (Fig. 6B), supporting the
idea that FX neither ameliorates nor aggravates CNS parasitism.
Furthermore, comparable intensities of inﬂammatory cell inﬁl-
trates were found in the CNS of mice from all analyzed groups
(Fig. 6B). Moreover, when mice treated with Bz during the acute
phase of T. cruzi infection (from 14 to 44 dpi) were subjected to
the TST during chronic infection (at 90 dpi), the beneﬁcial effect
of Bz on depressive-like behavior was still apparent (Fig. 6C;
p < 0.01; H (3) = 13.94). Collectively, these data show that the in-
creased immobility times observed in T. cruzi-infected mice are re-
duced by treatment the decreases parasite load, which supports
the direct or indirect participation of T. cruzi in triggering chronic
depressive-like behavior.
3.8. TNF-modulating drugs abolish depressive-like behavior
IFNc- and TNF-induced IDO activation is associated with
depressive behavior (Dantzer et al., 2008). The administration of
TNF to mice induces acute depressive-like behavior (Kaster et al.,
2012). Furthermore, consistent increases in TNF expression have
been associated with the severity of chronic Chagas disease (Lan-
nes-Vieira et al., 2011). Therefore, we investigated the participa-
tion of TNF in depressive-like behavior during chronic T. cruzi
infection. Concomitant with the depressive-like behavior revealed
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ically T. cruzi-infected (120 dpi) mice exhibited elevated serum TNF
levels compared with sex- and age-matched NI controls (Fig. 7A).
Infection by T. cruzi did not alter TNF mRNA expression in tissue
from the whole (Fig. 7B); however, TNF mRNA expression was
upregulated in the cardiac tissue at 120 dpi (Fig. 7B). Given that
FX decreased the T. cruzi-induced increase in immobility time
(Figs. 5 and 6) and the previous demonstration that FX exhibits
anti-inﬂammatory activity (Abdel-Salam et al., 2004; Koh et al.,
2011), we tested whether the beneﬁcial effect of the SSRI FX was
associated with the systemic down-regulation of TNF mRNA. As
shown in Fig. 7C, FX administration had no effect on TNF mRNA
expression, which was detected at similar levels in the cardiac tis-
sue of saline- and FX-treated infected C57BL/6 mice. Therefore, the
beneﬁcial action of the SSRI FX was independent of interference in
TNF status. Lastly, we tested whether TNF modulators inhibit T.
cruzi-induced depressive-like behavior. When chronically T. cruzi-
infected C57BL/6 mice were treated for 30 days (from 120 to
149 dpi) with the immunomodulator pentoxifylline (PTX, daily)
or the chimeric anti-TNF neutralizing monoclonal antibody inﬂix-
imab (anti-TNF, at 48-h intervals) and analyzed at 150 dpi
(Fig. 7D), no parasite burden was observed (data not shown). Nota-
bly, PTX and anti-TNF therapies have a beneﬁcial effect that signif-
icantly reduces TST immobility times compared with vehicle-
treated T. cruzi-infected mice (Fig. 7D; p < 0.05; H (2) = 14.09).
Thus, parasite-triggered systemic TNF upregulation contributes to
the depressive-like behavior in chronic T. cruzi infection.4. Discussion
The present study was conducted to test the contribution of T.
cruzi-induced CNS inﬂammation and the parasite strain infecting
the host to chronic behavioral alterations. Mice of the C3H/He line-
age infected with the type I Colombian T. cruzi strain, a model of
self-resolving acute phase-restricted brain inﬂammation, present
depressive-like behavior during the chronic phase of infection,
supporting the idea that depressive status is independent of active
CNS inﬂammation. Using infected C57BL/6 mice, which are refrac-
tory to acute brain inﬂammation, we conﬁrmed that behavioral
alterations were independent of the acute brain inﬂammation
and, therefore, not a long-term consequence of this inﬂammatory
process. However, the induction of chronic depressive-like behav-
ior was dependent on the T. cruzi strain infecting the host. Further-
more, T. cruzi-induced depressive-like behavior was paralleled by
increased IDO mRNA expression in the CNS and abrogated by the
SSRI antidepressant drug FX. Moreover, this behavioral alteration
was inhibited by the trypanocide drug Bz, conﬁrming that the par-
asite plays a direct or indirect protagonistic role in the induction of
depressive-like behavior. Finally, we provided evidence that TNF
plays a pivotal role as an immunological stressor in depressive-like
behavior during chronic T. cruzi infection.
The effects on the CNS during the acute phase of T. cruzi infec-
tion have been related to neurocognitive and/or cerebellar syn-
dromes during chronic infection (Spina-Franca, 1998; Pittella,
2009). Therefore, we hypothesized that the behavioral abnormali-
ties described in chronic Chagas disease (Prost et al., 2000; Moso-
vich et al., 2008; Silva et al., 2010) are long-term consequences of
acute CNS inﬂammation. To investigate this hypothesis, we in-
fected C3H/He and C57BL/6 mice with a low inoculum of the type
I Colombian T. cruzi strain that, without trypanocide therapy, re-
sults in acute phase survival (80%) and the establishment of
chronic infection. Most importantly, the T. cruzi-infected C3H/He
mice exhibited acute phase-restricted self-resolving CNS inﬂam-
mation, whereas the infected C57BL/6 mice were refractory to
brain inﬂammation, consistent with previous data (Silva et al.,1999; Roffê et al., 2003). Therefore, these models were suitable
to investigate our original proposal. We tested whether T. cruzi
infection led to behavior alterations in infected mice using the
open-ﬁeld test to assess locomotor/anxiety abnormalities (Hall,
1941) and the FST and TST to evaluate depressive-like behavior
(Porsolt, 2000; Steru et al., 1985; Ma et al., 2011; Painsipp et al.,
2011). T. cruzi-infected C57BL/6 mice had abnormalities compati-
ble with locomotor/exploratory alterations and anxiety in the
open-ﬁeld test in the acute and chronic phases, as previously de-
scribed (Silva et al., 2010). Conversely, using the open-ﬁeld test,
neither locomotor abnormalities nor anxiety were detected in
acute or chronically T. cruzi-infected C3H/Hemice. This ﬁnding cor-
roborated previous data showing that, regardless of the level of
CNS parasitism and inﬂammation, T. cruzi-infected animals have
no locomotor alterations in the acute infection phase (Caradonna
and Pereiraperrin, 2009). Our current data extend this concept
and suggest that the persistence of the parasite in the CNS during
the chronic phase does not cause locomotor/exploratory abnor-
malities during T. cruzi infection. Interestingly, recent data support
the idea that the CNS inﬂammation induced by acute stress is neu-
roprotective, at least for anxiety (Lewitus et al., 2008). In our
experiments, C57BL/6 mice were refractory to T. cruzi-induced
CNS inﬂammation, whereas C3H/He mice presented acute phase-
restricted meningoencephalitis with enrichment in CD8+ T-cells
andmacrophages (Silva et al., 1999; Roffê et al., 2003). Accordingly,
the selective trafﬁcking of inﬂammatory cells to the CNS may ex-
plain the differential responses of the resistant C3H/He mice and
susceptible C57BL/6 mice to T. cruzi-induced locomotor/explor-
atory alteration that may indicate anxiety; however, further stud-
ies are needed to determine the mechanism of this difference.
Studies conducted in patients with chronic Chagas disease have
revealed the presence of cephalea, confusion and depression (Jorg
and Rovira, 1981; Mangone et al., 1994; Marchi et al., 1998). These
data led us to investigate T. cruzi-induced depressive-like behavior
in C3H/He and C57BL/6 mouse models that reproduce important
pathological aspects of Chagas disease (Medeiros et al., 2009; Silva
et al., 2010; Silverio et al., 2012). Notably, our experiments showed
that, when infected with a low inoculum of the type I Colombian
strain, neither mouse lineage presented sickness-related behavior.
Moreover, our results show that T. cruzi-infected C3H/He mice,
which are susceptible to acute phase-restricted CNS inﬂammation,
exhibit depressive-like behavior during the acute and chronic
phases of infection. Therefore, this behavioral alteration was inde-
pendent of active CNS inﬂammation, supporting the hypothesis
that the chronic depressive-like behavior could be a long-term
consequence of acute brain inﬂammation. However, T. cruzi-in-
fected C57BL/6 mice, which are refractory to CNS inﬂammation,
also displayed depressive-like behavior during the acute and
chronic phases of infection. Thus, our ﬁndings suggest that T. cru-
zi-induced depression is independent of the active and previous
trafﬁcking of inﬂammatory cells to the CNS. Therefore, other bio-
logical mechanisms must explain the genesis of the chronic
depression associated with T. cruzi infection.
Given the genotypic and biological heterogeneity of T. cruzi
strains (Zingales et al., 2012), we attempted to clarify whether
chronic depressive status was associated with the parasite strain
infecting the host. Toward this end, we tested type I Colombian
and type II Y T. cruzi strains, parasite prototypes that represent
the strains most frequently found in nature (Zingales et al.,
2012). Infection with the type I Colombian strain led to acute
(21, 30 dpi) and chronic (90, 120 and 150 dpi) depressive-like
behavior in C3H/He mice. However, the enhanced immobility time
due to infection with the type II Y T. cruzi strain was restricted to
the acute infection (7 and 14 dpi), which may be linked to the
weight loss and temperature alteration indicators of sickness
behavior (da Silva et al., 2012), but did not cause chronic depres-
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tion being detected in the CNS until late infection (35 dpi). Thus,
these data show that in situ inﬂammation is not a crucial determi-
nant of T. cruzi-induced depressive-like behavior. Moreover, the
kinetics of the colonization of the CNS by the parasite suggests that
the presence of T. cruzi in the CNS is not a crucial cause of depres-
sion; CNS parasitism persisted at 35 dpi, when immobility time in
the TST was similar to NI controls. However, when acutely Colom-
bian-infected animals were treated with the parasiticide drug Bz,
parasitemia (indicative of systemic parasitism) and CNS parasitism
were controlled, as expected (Silva et al., 2010). In parallel, de-
creased immobility times were observed in the TST and FST. To-
gether, these results indicate direct or indirect systemic roles for
the parasite and/or parasite-induced factors in the induction of
depressive-like behavior. Interestingly, T. cruzi trans-sialidase (also
known as parasite-derived neurotrophic factor – PDNF) activates
the neurotrophic receptor TrkC, promoting the survival of neuronal
and glial cells; this raises the possibility that the recognition of
TrkC underlies the regenerative events in the nervous tissues of pa-
tients with Chagas disease (Weinkauf and Pereiraperrin, 2009).
Thus, our data showing Y-strain parasite persistence in the CNS
at 35 dpi in the absence of depressive-like behavior may support
a neuroprotective role of parasite persistence in the CNS. In the
chronically Colombian-infected C57BL/6 and C3H/He mice, depres-
sive-like behavior was present in the absence and presence of rare
parasites in the CNS. Therefore, further studies are warranted to
elucidate the mechanisms governing the relationship between T.
cruzi and the host that might protect or contribute to chronic
behavioral abnormalities. Other intracellular parasites that afﬂict
the brain, such as Plasmodium and Toxoplasma, also cause cognitive
disturbances (Idro et al., 2007; Zhu, 2009). It is possible that, in
apparently silent brain forms, these parasites can modify synaptic
circuits. Interestingly, in rodents, chronic Toxoplasma infection is
associated with behavioral alterations that enhance the risk of fe-
line predation, a putative selective advantage to the parasite (Hol-
liman, 1997; Silva and Langoni, 2009). Perhaps depressive-like
behavior in hosts such as rodents, other sylvatic animals and hu-
mans may also confer a selective advantage for T. cruzi.
The knowledge of being a Chagas disease carrier can elicit psy-
chological disturbances, particularly because there is no cure for
this disease (Petana, 1980; Mota et al., 2006). The demonstration
that treatment with Bz during the acute experimental infection
had a beneﬁcial effect and abolished depressive-like behavior in
the chronic phase of infection places the parasite as the central
trigger of the behavioral alterations and reinforces the requirement
for prompt diagnosis and etiological treatment of infected patients
(Lannes-Vieira et al., 2010; Rassi et al., 2010).
Chagas disease is considered a suitable model for studying the
association between depression and heart disease in the presence
of chronic inﬂammation (Mosovich et al., 2008). In fact, our exper-
imental models are appropriate for studying such an association
because Colombian T. cruzi-infected mice of the C3H/He and
C57BL/6 lineages that present chronic depressive behavior repro-
duce aspects of human Chagas disease (Dutra et al., 2009; Rassi
et al., 2010) such as chronic heart inﬂammation and systemic im-
mune dysbalance favoring IFNc and TNF (Medeiros et al., 2009).
The pro-inﬂammatory cytokines IFNc and TNF enhance tryptophan
degradation by IDO; this effect has important neuropsychiatric
implications because tryptophan catabolites (TRYCATs) may in-
duce neurodegeneration and tryptophan is a precursor of serotonin
(Dantzer et al., 2008; Maes et al., 2009). A previous study demon-
strated that tryptophan degradation and IDO expression are in-
creased in the spleen and muscles in acutely T. cruzi-infected
mice and associated IDO with resistance to infection (Knubel
et al., 2010). Thus, given that IDO ﬂuctuation in the CNS may affect
serotonin and contribute to depression (Dantzer et al., 2008), weassessed IDO mRNA expression in the CNS of T. cruzi-infected mice.
Our data showed remarkable increases in IDO mRNA expression in
the CNS of acutely and chronically T. cruzi-infected mice; therefore,
locally enhanced IDO may contribute to serotonin paucity and the
depressive-like behavior observed in these mice. Moreover, in-
fected mice of both lineages are responsive to FX, an SSRI antide-
pressant (Vaswani et al., 2003). Therefore, depressive-like
behavior may be caused by direct or indirect effects of T. cruzi-trig-
gered TRYCATs or alterations in serotonin synthesis.
Pathogen-borne products and host immune response mediators
such as glucocorticoids and cytokines may contribute to depres-
sion (Dantzer et al., 2008; Maes et al., 2009; Gibb et al., 2011).
TNF, which affects T cells and increases glucocorticoid levels and
apoptosis, may play a role in depression (Miller, 2010; Rook
et al., 2011). Apparently, in T. cruzi infection, the local acute CNS
inﬂammation does not inﬂuence the depressive proﬁle. Therefore,
based on the effect of T. cruzi infection on immune system activa-
tion (Junqueira et al., 2010), we hypothesized that pro-inﬂamma-
tory cytokines may contribute to T. cruzi-induced depressive-like
behavior. Systemic immune abnormalities are commonly found
in the chronic phase of T. cruzi infection in both C3H/He and
C57BL/6 mice (Medeiros et al., 2009; Silverio et al., 2012). In chron-
ically Colombian-infected C57BL/6 mice, behavioral alterations
were paralleled by increases in TNF expression in the serum and
cardiac tissue but not in the CNS, suggesting a possible role for sys-
temically produced TNF in T. cruzi-induced depression.
The SSRI antidepressant FX has anti-inﬂammatory activity; it
decreases IFNc, upregulates IL-10 and inhibits the activation of
NF-jB (Abdel-Salam et al., 2004; Koh et al., 2011). NF-jB is a
nuclear factor crucial for TNF gene transcription (Tracey et al.,
2008). Hence, we tested whether the beneﬁcial effect of FX in
T. cruzi-induced depressive disorder was related to the systemic
down-regulation of TNF mRNA. This was not the case, however,
as similar TNF mRNA levels were detected in saline- and FX-
treated T. cruzi-infected mice. Subsequently, the participation of
TNF in T. cruzi-induced depressive-like behavior was tested by
treating chronically (120 dpi) T. cruzi-infected C57BL/6 mice with
PTX, a phosphodiesterase inhibitor that decreases TNF synthesis
(Shaw et al., 2009), or the chimeric anti-TNF neutralizing mono-
clonal antibody inﬂiximab (Tracey et al., 2008). Although TNF
plays an important role in parasite control in the acute phase
of infection (Lannes-Vieira et al., 2011), no parasite burden was
observed, suggesting that infection was not reactivated or reacu-
tized by interfering with TNF in chronically T. cruzi-infected
mice. Importantly, the immobility time assessed by the TST
was signiﬁcantly decreased after PTX and anti-TNF administra-
tion, supporting the idea that TNF may have a pivotal role in
the induction of depressive-like behavior during chronic infec-
tion. Accordingly, exogenous TNF administration induces acute
depressive-like behavior, supporting a role for this cytokine in
behavioral alterations (Kaster et al., 2012). Despite the very
low parasite load, patients develop more severe forms of Chagas
disease during the chronic stage (Dutra et al., 2009; Rassi et al.,
2010), when high TNF levels in the serum are detected (Ferreira
et al., 2003; Talvani et al., 2004; Gomes et al., 2005). Our study
highlights that T. cruzi-induced long-lasting TNF expression may
contribute to depressive-like behavior in Chagas disease. Because
non-infectious chronic cardiac disorders are associated with high
TNF levels (Shaw et al., 2009), our ﬁndings become more broadly
important. Interestingly, Bz and PTX also regulate NF-jB activa-
tion (Shaw et al., 2009; Manarin et al., 2010). Therefore, the gen-
esis of depressive-like behavior in Chagas disease may reside in
a complex network of interactions triggered by the parasite that
involve the immune stressor TNF and mechanisms that may in-
duce increase in TRYCATs and serotonin paucity (Fig. S4). Alto-
gether, our ﬁndings support the existence of a chronic nervous
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ogen-borne cytokine-driven chronic depression and open new
avenues for therapeutic interventions in depressive disorders.5. Conclusion and limitations
Our results indicate that T. cruzi infection provokes a cytokine-
driven depressive-like behavior in experimental models indepen-
dent of active or prior acute CNS inﬂammation. In our studies,
the TST and FST used to assess depressive-like behavior are based
on immobility, restringing the strength of our ﬁndings. The use
tests based on other behavioral paradigm as food consumption
including the sucrose preference test, was hampered in this model
of parasitic infection as sugar consumption may fuel parasite
growth. In T. cruzi-infected mice impaired pancreas morphology
and glucose metabolism was associated with increased glycemia
(Novaes et al., 2012), a condition which increased parasitemia
and mortality (Tanowitz et al., 1988). Importantly, trypanocide
therapy administered during the acute infection promptly abro-
gated chronic depression; this ﬁnding supports a direct or indirect
contribution of the parasite and parasite-triggered factors in
depression. Furthermore, T. cruzi-induced IDO upregulation and
the beneﬁcial effect of the SSRI FX in reducing immobility time
may implicate serotonin paucity in this process. Moreover, T. cruzi
infection systemically upregulates TNF and the TNF modulators
PTX and anti-TNF have beneﬁcial effects on chronic depression,
reinforcing the inﬂammatory component of depressive disorders.
Thus, our data open a new avenue for exploration regarding the
parasite factors and molecular mechanisms governing behavioral
alterations in Chagas disease. More broadly, our ﬁndings disclose
PTX as a therapeutic tool that should be further explored in chronic
depressive disorders.
Additional studies are required to clarify whether functional
and structural brain pathology play roles in the development
of mood disorders in Chagas disease. Parasite/host interactions
are highly complex and may diverge in speciﬁc sites inside the
host. In the present work, these complex interactions are exem-
pliﬁed by the detection of increased TNF expression systemically
and in heart tissue but not in the whole brain of T. cruzi-infected
mice. Further experiments are required to clarify whether TNF is
expressed at low levels in distinct CNS regions during T. cruzi
infection. Additionally, the fact that FX did not modulate system-
ically produced TNF precludes ruling out the possibility that this
may occur in discrete CNS areas. Additionally, the beneﬁcial ef-
fect of the SSRI FX on T. cruzi-induced depression may reside
in an alternative cytokine circuit not explored in our study.
Lastly, in the present work, we did not explore the mechanisms
of the beneﬁcial effect of TNF blockers in chronic depression.
Further efforts to decipher whether TNF blockers interfere with
cytokine-driven tryptophan deprivation or with a currently
unknown pathway are warranted.Acknowledgments
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